Ewha Clinical Trial Center
Ewha Clinical Trial Center was established to promote the world-class infrastructure for clinical trials, protection of study participants and researchers, education of professionals, and development of clinical research and technology.
The Center has made utmost efforts to promote public health through scientific and systematic clinical studies. In order to conduct the clinical tests to evaluate efficacy and safety of medicines and medical devices in an ethical and scientific manner, the Center provides researchers with research facilities and administrative support.
Ewha Institute of Convergence Medicine
Ewha Institute of Convergence Medicine plays a role as a core for industrialization of medical service and jumping up to a global research focused hospital by improving health and medical technology of EUMC dramatically through organic cooperation system between basic and clinical research.
This institute focuses on research of 6 areas such as cancer, cerebral cognition disorder, serious and intractable disease, women's metabolic disease, vascular disease, and medical engineering and new concept radiology and plays a role as a core to strengthen international competitiveness of the Cancer Center for Women by studying gynecologic cancers intensively and connecting the results to improvement of medical service quality.
Ewha Womans University Innovative Research Center for Control and Prevention of Women's Cancer
EUMC opened Ewha Womans University Cancer Center for Women and has grown and developed aiming at the world best Cancer Center for Women. It is performing active basic-clinical translational studies based on Ewha Institute of Convergence Medicine and secures know-hows by performing a number of clinical trials through Clinical Trial Center. Currently, a number of clinical trials including multi-national clinical trials are being progressed.
On the basis of these strong points, Ewha Womans University Innovative Research Center for Control and Prevention of Women's Cancer was assigned as a National Hospital Specialization Research Center by the Ministry of Health and Welfare in 2012. This center is making efforts for development of accurate early diagnostic methods and innovative therapies required for refractory gynecologic cancers and independence of the center through the aboves.